Juan-juan Liu

Shengjing Hospital Affiliated To China Medical University 36 Sanhao Street
Shenyang, 110004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

First case of endometrial cancer after yolk sac tumor in a patient with Li-Fraumeni syndrome.

First case of endometrial cancer after yolk sac tumor in a patient with Li-Fraumeni syndrome.

Journal: BMC women's health

Published: June 06, 2022

Human epididymis protein 4 promotes P‑glycoprotein‑mediated chemoresistance in ovarian cancer cells through interactions with Annexin II.

Human epididymis protein 4 promotes P‑glycoprotein‑mediated chemoresistance in ovarian cancer cells through interactions with Annexin II.

Journal: Molecular medicine reports

Published: August 17, 2020

Overexpression of TEM8 promotes ovarian cancer progression via Rac1/Cdc42/JNK and MEK/ERK/STAT3 signaling pathways.

Overexpression of TEM8 promotes ovarian cancer progression via Rac1/Cdc42/JNK and MEK/ERK/STAT3 signaling pathways.

Journal: American journal of translational research

Published: December 12, 2019

Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer.

Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer.

Journal: Journal of translational medicine

Published: February 14, 2019

TMEFF1 overexpression and its mechanism for tumor promotion in ovarian cancer.

TMEFF1 overexpression and its mechanism for tumor promotion in ovarian cancer.

Journal: Cancer management and research

Published: January 31, 2019

Decreased expression of peroxiredoxin1 inhibits proliferation, invasion, and metastasis of ovarian cancer cell.

Decreased expression of peroxiredoxin1 inhibits proliferation, invasion, and metastasis of ovarian cancer cell.

Journal: OncoTargets and therapy

Published: November 23, 2018

Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.

Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.

Journal: Journal of cellular physiology

Published: September 13, 2018

Screening of prognostic biomarkers for endometrial carcinoma based on a ceRNA network.

Screening of prognostic biomarkers for endometrial carcinoma based on a ceRNA network.

Journal: PeerJ

Published: May 17, 2018

Expressions of CD44,CD47,and c-met in Ovarian Clear Cell Carcinoma and Their Clinical Significance.

Expressions of CD44,CD47,and c-met in Ovarian Clear Cell Carcinoma and Their Clinical Significance.

Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae

Published: January 10, 2017

Whole Genome Expression Profiling Analysis of Metastasis and Drug-resistance-related Genes in Epithelial Ovarian Cancer Cells

Whole Genome Expression Profiling Analysis of Metastasis and Drug-resistance-related Genes in Epithelial Ovarian Cancer Cells

Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae

Published: January 05, 2016

Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer.

Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer.

Journal: American journal of cancer research

Published: November 10, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026